| | ||||||||||
| 1 | INN | Class | Route (list) | PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that the equation t1/2 = VD / Cl * 0.693 was used | Primary Target and PDB code of Protein-Drug complex | Targets from DrugCentral | Links | |||
| LURBINECTEDIN
| LURBINECTEDIN | ANTINEOPLASTIC | INTRAVENOUS | Cmax 136.3 NANOMOLAR VD 504 LITER PPB 99 PERCENT Cl 11 LITER / HOUR HT 51 HOUR | DNA | Unknown more at DrugCentral | EMA | |||
